Cite
Individualized induction chemotherapy by pre-treatment plasma Epstein-Barr viral DNA in advanced nasopharyngeal carcinoma
MLA
Li Tian, et al. “Individualized Induction Chemotherapy by Pre-Treatment Plasma Epstein-Barr Viral DNA in Advanced Nasopharyngeal Carcinoma.” BMC Cancer, vol. 18, Dec. 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....6258bd81d3ffb830535b004d72d32da5&authtype=sso&custid=ns315887.
APA
Li Tian, Wen Fei Li, Li Zhi Liu, Jian Zhang, Hao Peng, Ying Sun, Ai Hua Lin, Jun Ma, & Yuan Zhang. (2018). Individualized induction chemotherapy by pre-treatment plasma Epstein-Barr viral DNA in advanced nasopharyngeal carcinoma. BMC Cancer, 18.
Chicago
Li Tian, Wen Fei Li, Li Zhi Liu, Jian Zhang, Hao Peng, Ying Sun, Ai Hua Lin, Jun Ma, and Yuan Zhang. 2018. “Individualized Induction Chemotherapy by Pre-Treatment Plasma Epstein-Barr Viral DNA in Advanced Nasopharyngeal Carcinoma.” BMC Cancer 18 (December). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....6258bd81d3ffb830535b004d72d32da5&authtype=sso&custid=ns315887.